...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

narmac here is the pipeline. Nothing beyond Phase 2 just yet.

https://www.zenithepigenetics.com/programs/pipeline

Are you the one that's doing all the buying :)

A copy of the management present may be foundĀ HERE

Koo

Share
New Message
Please login to post a reply